Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Russian drones injure 19, cause extensive damage in Ukraine's Zaporizhzhia
Israel launches new military operation in northern West Bank
Australian teenagers ask High Court to block social media ban
India lodges strong protest with China over detention of Indian woman
Four dead after fire engulfs residential high-rise buildings in Hong Kong
